©The Author(s) 2018.
World J Gastroenterol. Nov 21, 2018; 24(43): 4950-4958
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4950
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4950
Table 1 Clinical characteristics of the patients
| Characteristic | CRCIS (n = 114) | CRC (n = 114) | P value |
| Age | 65.33 ± 12.45 | 63.67 ± 9.18 | 0.748a |
| Gender | |||
| Male, n (%) | 78 (68.42) | 78 (68.42) | 1.000b |
| Female, n (%) | 36 (31.58) | 36 (31.58) | |
| Blood tests | |||
| WBC (109/L) | 7.71 ± 2.27 | 7.18 ± 1.97 | 0.058a |
| HGB (g/L) | 114.96 ± 23.09 | 122.57 ± 85.55 | 0.360a |
| PLT (109/L) | 242.28 ± 116.46 | 235.51 ± 82.35 | 0.613a |
| NC (109/L) | 5.65 ± 2.28 | 4.16 ± 1.49 | < 0.001a |
| PT (s) | 10.94 ± 1.40 | 10.82 ± 0.98 | 0.474a |
| INR | 0.95 ± 0.13 | 0.92 ± 0.08 | 0.137a |
| APTT (s) | 29.52 ± 6.79 | 30.11 ± 6.20 | 0.496a |
| FIB (g/L) | 5.42 ± 4.42 | 5.32 ± 4.74 | 0.862a |
| D-dimer (μg/mL) | 1.40 ± 0.93 | 0.56 ± 0.47 | < 0.001a |
| CRP (mg/L) | 33.54 ± 35.50 | 28.79 ± 34.38 | 0.431a |
| CEA (U/mL) | 222.31 ± 175.85 | 88.48 ± 55.04 | < 0.001a |
| CA125 (U/mL) | 47.13 ± 54.32 | 22.70 ± 34.61 | < 0.001a |
| CA199 (U/mL) | 293.41 ± 1428.18 | 24.83 ± 34.212 | 0.066a |
| Type of CRC | |||
| Adenocarcinoma | 107 | 110 | 0.235b |
| Nonadenocarcinoma | 7 | 4 | |
| Systemic metastasis, n (%) | 0.080b | ||
| Yes | 74 (64.9) | 61 (53.5) | |
| No | 40 (35.1) | 53 (46.5) | |
| Methods of therapy, n (%) | |||
| Surgery | 76 (66.7) | 87 (76.3) | 0.107b |
| Chemotherapy | 46 (40.4) | 33 (28.9) | 0.070b |
| No treatment | 28 (24.6) | 24 (21.2) | 0.528b |
- Citation: Qin QX, Cheng XM, Lu LZ, Wei YF, Wang DC, Li HH, Li GH, Liang HB, Li SY, Chen L, Liang ZJ. Biomarkers and potential pathogenesis of colorectal cancer-related ischemic stroke. World J Gastroenterol 2018; 24(43): 4950-4958
- URL: https://www.wjgnet.com/1007-9327/full/v24/i43/4950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i43.4950